en English

Eamon Hughes

My current work involves the use of a novel serum biomarker to detect tumour recurrence and monitor the treatment of recurrent tumours using the tyrosine kinase inhibiting drug, Dasatinib. Current grant funding from Science Foundation Ireland.

X